Battaglia TA, Roloff K, Posner MA, Freund KM Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007 Jan 15;109(2 Suppl):359-67.
Catalani C, Minkler M Photovoice: a review of the literature in health and public health. Health Educ Behav. 2010 Jun;37(3):424-51. doi: 10.1177/1090198109342084. Epub 2009 Oct 1. Review.
Centers for Disease Control and Prevention (CDC) State-specific secondhand smoke exposure and current cigarette smoking among adults - United States, 2008. MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1232-5.
Centers for Disease Control and Prevention (CDC) State-specific smoking-attributable mortality and years of potential life lost--United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2009 Jan 23;58(2):29-33. Erratum in: MMWR Morb Mortal Wkly Rep. 2009 Feb 6;58(4):91.
Chin MH, Walters AE, Cook SC, Huang ES Interventions to reduce racial and ethnic disparities in health care. Med Care Res Rev. 2007 Oct;64(5 Suppl):7S-28S.
Cokkinides VE, Halpern MT, Barbeau EM, Ward E, Thun MJ Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey. Am J Prev Med. 2008 May;34(5):404-12. doi: 10.1016/j.amepre.2008.02.003.
Condiotte MM, Lichtenstein E Self-efficacy and relapse in smoking cessation programs. J Consult Clin Psychol. 1981 Oct;49(5):648-58.
Crawford SL, Tennstedt SL, McKinlay JB A comparison of anlaytic methods for non-random missingness of outcome data. J Clin Epidemiol. 1995 Feb;48(2):209-19.
Curry SJ, Marlatt GA, Gordon J, Baer JS A comparison of alternative theoretical approaches to smoking cessation and relapse. Health Psychol. 1988;7(6):545-56.
Deci EL, Koestner R, Ryan RM A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull. 1999 Nov;125(6):627-68; discussion 692-700.
Dohan D, Schrag D Using navigators to improve care of underserved patients: current practices and approaches. Cancer. 2005 Aug 15;104(4):848-55.
Donatelle RJ, Prows SL, Champeau D, Hudson D Randomised controlled trial using social support and financial incentives for high risk pregnant smokers: significant other supporter (SOS) program. Tob Control. 2000;9 Suppl 3:III67-9.
Fang CY, Ma GX, Tan Y, Chi N A multifaceted intervention to increase cervical cancer screening among underserved Korean women. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1298-302.
Gilpin EA, Pierce JP, Farkas AJ Duration of smoking abstinence and success in quitting. J Natl Cancer Inst. 1997 Apr 16;89(8):572-6.
Kanner AD, Coyne JC, Schaefer C, Lazarus RS Comparison of two modes of stress measurement: daily hassles and uplifts versus major life events. J Behav Med. 1981 Mar;4(1):1-39.
Romano PS, Bloom J, Syme SL Smoking, social support, and hassles in an urban African-American community. Am J Public Health. 1991 Nov;81(11):1415-22.
Shoptaw S, Jarvik ME, Ling W, Rawson RA Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict Behav. 1996 May-Jun;21(3):409-12.
Sorensen G, Barbeau E, Hunt MK, Emmons K Reducing social disparities in tobacco use: a social-contextual model for reducing tobacco use among blue-collar workers. Am J Public Health. 2004 Feb;94(2):230-9. Review.
Van Etten ML, Higgins ST, Budney AJ, Badger GJ Comparison of the frequency and enjoyability of pleasant events in cocaine abusers vs. non-abusers using a standardized behavioral inventory. Addiction. 1998 Nov;93(11):1669-80.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.